ENBREL

Immunex Corporation🇺🇸 United States

FDA Page

Effective Date: May 11, 2026
Approval ID: a002b40c-097d-47a5-957f-7a7b1807af7f
Products: 11 registered
Version: 218

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ENBREL safely and effectively. See full prescribing information for ENBREL. ENBREL (etanercept) injection, for subcutaneous use ENBREL (etanercept) for injection, for subcutaneous use Initial U.S. Approval: 1998

Quick Stats

Total Products11

Labelers2

Label Sections41

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.